PASG Stock Analysis: Buy, Sell, or Hold?
PASG - Passage Bio, Inc. Common Stock
$6.24
-0.14 (-2.19%)
▼
5d:
-11.36%
30d:
-31.58%
90d:
-42.54%
HOLD
MODERATE Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 12, 2026
Get Alerted When PASG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PASG shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: PASG shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: PASG is currently trading at $6.24, which is considered oversold relative to its 30-day fair value range of $7.08 to $8.85.
Technical Outlook: Technically, PASG is showing sideways momentum. The price is currently testing key support at $6.54. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PASG has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $30.80 (+382.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PASG is showing sideways momentum. The price is currently testing key support at $6.54. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PASG has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $30.80 (+382.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$7.08 -
$8.85
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 382.8% below Wall St target ($30.80)
- CAUTION: 5-day price weakness (-11.4%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$7.08 -
$8.85
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$6.54
Resistance Level
$8.09
Current Trend
Sideways
Technical data as of
Mar 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.19
Wall Street Target
$30.80
(+382.8%)
Share & Embed Analysis
Last updated: March 30, 2026 10:14 AM ET
Data refreshes hourly during market hours. Next update: 11:14 AM
Data refreshes hourly during market hours. Next update: 11:14 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PASG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
William Chou
SELL
4076 shares
2026-01-08
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$222 | 62 BUY |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$92 | 62 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$54 | 54 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$108 | 63 BUY |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
15 analysts |
$669 | 65 BUY |